Hormonal contraception and breast cancer

Area of Science:

• Reproductive Health
• Oncology
• Epidemiology

Background:

• Hormonal contraception is widely used globally.
• Previous studies suggest a potential link between hormonal contraceptive use and breast cancer risk.
• The magnitude and duration of this risk require further clarification.

Purpose of the Study:

• To investigate the association between hormonal contraception use and breast cancer risk in a Danish cohort.
• To examine risk factors related to duration of use and specific hormonal contraceptive formulations.
• To assess the long-term cancer risk associated with hormonal contraception.

Main Methods:

• Retrospective cohort study design.
• Analysis of data from a large Danish population.
• Comparison of breast cancer incidence among users and non-users of hormonal contraception.

Main Results:

• A 20% increased risk of breast cancer was observed in current and recent hormonal contraception users.
• An increasing risk was associated with longer duration of current use.
• An increased risk was noted with the use of the levonorgestrel intrauterine system.
• The study did not report on disease stage at diagnosis or specific low-dose ethinyl estradiol pill risks.
• Observed breast cancer risks diminish over time after cessation of use.

Conclusions:

• Hormonal contraception use is associated with a modest, short-term increase in breast cancer risk.
• Longer duration of use and specific formulations like the levonorgestrel intrauterine system warrant further investigation.
• Long-term hormonal contraception use is not associated with an increased overall cancer risk.